Janus Living 

$23.85
120
+$0.48+2.05% Friday 20:00

Statistics

Day High
23.85
Day Low
23.36
52W High
24.36
52W Low
22.76
Volume
742,655
Avg. Volume
2,615,492
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Apr 22
$0.06
Jan 22
$0.46
Oct 21
$0.35
Jul 21
$0.35
Apr 21
$0.17
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

19MayExpected
Q4 0
Q1 2025
Q2 2025
Q4 2025
Q4 2025
Next
-0.36
-0.29
-0.21
-0.14
Expected EPS
-0.14
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
0Revenue
-7.81MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow JAN. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap161.09B
Pfizer is a global pharmaceutical company that competes with JanOne in the development of treatments for various diseases, including those JanOne targets with its non-opioid pain management solutions.
Johnson & Johnson
JNJ
Mkt Cap585.7B
Johnson & Johnson, through its pharmaceutical segment, competes in developing medications and treatments that can overlap with JanOne's focus areas, including pain management.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie operates in the pharmaceuticals sector, focusing on innovative therapies, directly competing with JanOne in areas like chronic pain treatment.
Merck
MRK
Mkt Cap298.84B
Merck is involved in the development and manufacturing of drugs that address serious health issues, competing with JanOne in the pharmaceutical space, especially in pain management solutions.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap35.03B
Teva Pharmaceutical Industries specializes in generic and specialty medicines, including pain management, making it a competitor to JanOne in the non-opioid pain relief market.
Novartis
NVS
Mkt Cap297.32B
Novartis is a global healthcare company that produces drugs in various therapeutic areas, including pain, competing with JanOne's mission to offer alternative pain solutions.
Bristol-Myers Squibb
BMY
Mkt Cap121.69B
Bristol Myers Squibb is a biopharmaceutical company that develops medicines in several therapeutic areas, potentially competing with JanOne in the area of pain management.
Lilly(Eli) &
LLY
Mkt Cap837.36B
Eli Lilly and Company focuses on pharmaceuticals in areas that could compete with JanOne, especially considering their work on pain and chronic conditions.
GSK
GSK
Mkt Cap113.29B
GlaxoSmithKline is a healthcare company that produces pharmaceuticals across various areas, including pain relief, making it a competitor to JanOne.
Sanofi
SNY
Mkt Cap116.63B
Sanofi is a global life sciences company that offers a broad range of medicines, including those for pain management, competing with JanOne's focus on non-opioid solutions.

Holdings

Regions

Sectors

About

JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. Its lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.
Show more...
CEO
Mr. Tony Isaac
Employees
5
Country
United States
ISIN
US4710241096

Listings

0 Comments

Share your thoughts

FAQ

What is Janus Living stock price today?
The current price of JAN is $23.85 USD — it has increased by +2.05% in the past 24 hours. Watch Janus Living stock price performance more closely on the chart.
What is Janus Living stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Janus Living stocks are traded under the ticker JAN.
When is the next Janus Living earnings date?
Janus Living is going to release the next earnings report on May 19, 2026.
What is Janus Living revenue for the last year?
Janus Living revenue for the last year amounts to 0 USD.
What is Janus Living net income for the last year?
JAN net income for the last year is -7.81M USD.
How many employees does Janus Living have?
As of April 11, 2026, the company has 5 employees.
In which sector is Janus Living located?
Janus Living operates in the Manufacturing sector.
When did Janus Living complete a stock split?
The last stock split for Janus Living was on April 22, 2019 with a ratio of 1:5.
Where is Janus Living headquartered?
Janus Living is headquartered in Las Vegas, United States.